Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

  1. Olsen M.A. et al. Risk Factors for Surgical Site Infection After Low Transverse Cesarean Section // Infect. Control Hosp. Epidemiol. Cambridge University Press (CUP), 2008. Vol. 29, № 6. P. 477–484.
  2. Korol E. et al. A systematic review of risk factors associated with surgical site infections among surgical patients // PLoS ONE. PLoS One, 2013. Vol. 8, № 12.
  3. Tran T.S. et al. Risk factors for postcesarean surgical site infection // Obstet. Gynecol. Obstet Gynecol, 2000. Vol. 95, № 3. P. 367–371.
  4. Avila C. et al. Association of smoking with wound complications after cesarean delivery // J. Matern. Neonatal Med. J Matern Fetal Neonatal Med, 2012. Vol. 25, № 8. P. 1250–1253.
  5. De Vivo A. et al. Wound length and corticosteroid administration as risk factors for surgical-site complications following cesarean section // Acta Obstet. Gynecol. Scand. Acta Obstet Gynecol Scand, 2010. Vol. 89, № 3. P. 355–359.
  6. Vermillion ST et al. Wound infection after cesarean: Effect of subcutaneous tissue thickness // Obstet. Gynecol. Obstet Gynecol, 2000. Vol. 95, № 6. P. 923–926.
  7. Killian C.A. et al. Risk Factors for Surgical-Site Infections Following Cesarean Section // Infect. Control Hosp. Epidemiol. Cambridge University Press (CUP), 2001. Vol. 22, № 10. P. 613–617.
  8. Opøien H.K. et al. Post-cesarean surgical site infections according to CDC standards: Rates and risk factors. A prospective cohort study // Acta Obstet. Gynecol. Scand. Acta Obstet Gynecol Scand, 2007. Vol. 86, № 9. P. 1097–1102.
  9. Schneid-Kofman N. et al. Risk factors for wound infection following cesarean deliveries // Int. J. Gynecol. Obstet. John Wiley and Sons Ltd, 2005. Vol. 90, № 1. P. 10–15.
  10. Eberlein T., Assadian O. Clinical use of polihexanide on acute and chronic wounds for antisepsis and decontamination // Skin Pharmacology and Physiology. Skin Pharmacol Physiol, 2010. Vol. 23, № SUPPL. 1. P. 45–51.
  11. James G.A. et al. Biofilms in chronic wounds // Wound Repair Regen. Wound Repair Regen, 2008. Vol. 16, № 1. P. 37–44.
  12. Siddiqui A.R., Bernstein J.M. Chronic wound infection: Facts and controversies // Clin. Dermatol. Clin Dermatol, 2010. Vol. 28, № 5. P. 519–526.
  13. Leaper D.J. et al. Extending the TIME concept: What have we learned in the past 10 years? // Int. Wound J. Int Wound J, 2012. Vol. 9, № SUPPL. 2. P. 1–19.
  14. Rouse C.E. et al. Postpartum endometritis and infection following incomplete or complete abortion: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data // Vaccine. Elsevier Ltd, 2019. Vol. 37, № 52. P. 7585–7595.
  15. Morgan J., Roberts S. Maternal Sepsis // Obstetrics and Gynecology Clinics of North America. Obstet Gynecol Clin North Am, 2013. Vol. 40, № 1. P. 69–87.
  16. Dalton E., Castillo E. Post partum infections: A review for the non-OBGYN // Obstet. Med. Royal Society of Medicine Press Ltd, 2014. Vol. 7, № 3. P. 98–102.
  17. Seale A.C. et al. Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children // Clin. Infect. Dis. Oxford University Press, 2017. Vol. 65, № suppl_2. P. S200–S219.
  18. Maharaj D. Puerperal pyrexia: A review. Part II // Obstetrical and Gynecological Survey. Obstet Gynecol Surv, 2007. Vol. 62, № 6. P. 400–406.
  19. Karsnitz DB. Puerperal infections of the genital tract: A clinical review // Journal of Midwifery and Women’s Health. John Wiley and Sons Inc., 2013. Vol. 58, № 6. P. 632–642.
  20. Mackeen A.D. et al. Antibiotic regimens for postpartum endometritis // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2015. Vol. 2015, № 2.
  21. Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery // Obstet. Gynecol. Ovid Technologies (Wolters Kluwer Health), 2002. Vol. 100, № 5. P. 959–964.
  22. Magann EF et al. Pregnancy, obesity, gestational weight gain, and parity as predictors of peripartum complications // Arch. Gynecol. Obstet. Arch Gynecol Obstet, 2011. Vol. 284, № 4. P. 827–836.
  23. Burrows L.J., Meyn L.A., Weber A.M. Maternal morbidity associated with vaginal versus cesarean delivery // Obstetrics and Gynecology. Obstet Gynecol, 2004. Vol. 103, № 5 I. P. 907–912.
  24. Boggess K.A. et al. Risk factors for postcesarean maternal infection in a trial of extended-spectrum antibiotic prophylaxis // Obstet. Gynecol. Lippincott Williams and Wilkins, 2017. Vol. 129, № 3. P. 481–485.
  25. Liu D. et al. Different regimens of penicillin antibiotics given to women routinely for preventing infection after cesarean section: A systematic review and meta analysis // Medicine (United States). Lippincott Williams and Wilkins, 2018. Vol. 97, № 46.
  26. Анохова Л.И. et al. Послеродовый эндометрит и его профилактика (обзор литературы). 2016. 6–13 p.
  27. Докудаева Ш.А. Современные представления об этиологии, патогенезе, клинике и диагностике послеродового эндометрита // Вестник Национального медико-хирургического Центра им. Н. И. Пирогова. 2016. Vol. 11, № 4. P. 109–115.
  28. Мартынов С.А., Адамян Л.В. Рубец на матке после кесарева сечения: терминологические аспекты // Гинекология. 2020. Vol. 22, № 5. P. 70–75.
  29. Sartelli M. et al. Complicated intra-abdominal infections worldwide: The definitive data of the CIAOW Study // World J. Emerg. Surg. BioMed Central Ltd., 2014. Vol. 9, № 1.
  30. Bassetti M. et al. A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality // Intensive Care Med. Springer Verlag, 2014. Vol. 40, № 6. P. 839–845.
  31. Osuchowski M.F. et al. Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality // J. Immunol. The American Association of Immunologists, 2006. Vol. 177, № 3. P. 1967–1974.
  32. Kirkpatrick A.W. et al. Update from the abdominal compartment society (WSACS) on intra-Abdominal hypertension and abdominal compartment syndrome: Past, present, and future beyond Banff 2017 // Anaesthesiology Intensive Therapy. Via Medica, 2017. Vol. 49, № 2. P. 83–87.
  33. Reintam Blaser A. et al. Incidence, Risk Factors, and Outcomes of Intra-Abdominal Hypertension in Critically Ill Patients - A Prospective Multicenter Study (IROI Study) // Crit. Care Med. Lippincott Williams and Wilkins, 2019. Vol. 47, № 4. P. 535–542.
  34. Cantwell R et al. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008 // BJOG An Int. J. Obstet. Gynaecol. Wiley, 2011. Vol. 118. P. 1–203.
  35. Reusch M. et al. Prevalence of MRSA colonization in peripartum mothers and their newborn infants // Scand. J. Infect. Dis. Taylor & Francis, 2008. Vol. 40, № 8. P. 667–671.
  36. Hassoun A., Linden P.K., Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment // Critical care (London, England). Crit Care, 2017. Vol. 21, № 1. P. 211.
  37. Bowyer L. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the UK // Obstet. Med. SAGE Publications, 2008. Vol. 1, № 1. P. 54–54.
  38. Stefonek K.R., Maerz L.L., Nielsen M.P. Group A streptococcal puerperal sepsis preceded by positive surveillance cultures // Obstet. Gynecol. Obstet Gynecol, 2001. Vol. 98, № 5. P. 846–848.
  39. Barnham M.R.D., Weightman N.C. Bacteraemic Streptococcus pyogenes infection in the peri-partum period: Now a rare disease and prior carriage by the patient may be important // J. Infect. W.B. Saunders Ltd, 2001. Vol. 43, № 3. P. 173–176.
  40. Raymond S.L. et al. Microbial recognition and danger signals in sepsis and trauma // Biochimica et Biophysica Acta - Molecular Basis of Disease. Elsevier B.V., 2017. Vol. 1863, № 10. P. 2564–2573.
  41. Takeuchi O., Akira S. Pattern Recognition Receptors and Inflammation // Cell. Elsevier B.V., 2010. Vol. 140, № 6. P. 805–820.
  42. D́elia R. V. et al. Targeting the “Cytokine Storm” for Therapeutic Benefit // Clinical and Vaccine Immunology. Clin Vaccine Immunol, 2013. Vol. 20, № 3. P. 319–327.
  43. World Health Organization. Global report on the epidemiology and burden of sepsis: current evidence, identifying gaps and future directions. 2020.
  44. Say L. et al. Global causes of maternal death: A WHO systematic analysis // Lancet Glob. Heal. Elsevier Ltd, 2014. Vol. 2, № 6.
  45. Souza J.P. et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): A cross-sectional study // Lancet. Elsevier B.V., 2013. Vol. 381, № 9879. P. 1747–1755.
  46. Bonet M. et al. Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study // Lancet Glob. Heal. Elsevier Ltd, 2020. Vol. 8, № 5. P. e661–e671.
  47. Blumenfeld Y.J. et al. Risk Factors for Prolonged Postpartum Length of Stay Following Cesarean Delivery // Am. J. Perinatol. Thieme Medical Publishers, Inc., 2015. Vol. 32, № 9. P. 825–832.
  48. Costantine M.M. et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis // Am. J. Obstet. Gynecol. Mosby Inc., 2008. Vol. 199, № 3. P. 301.e1-301.e6.
  49. Smaill F.M., Grivell R.M. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2014. Vol. 2014, № 10.
  50. Steiner HL, Strand EA. Surgical-site infection in gynecologic surgery: pathophysiology and prevention // Am. J. Obstet. Gynecol. Am J Obstet Gynecol, 2017. Vol. 217, № 2. P. 121–128.
  51. Singer M. et al. The third international consensus definitions for sepsis and septic shock (sepsis-3) // JAMA - Journal of the American Medical Association. American Medical Association, 2016. Vol. 315, № 8. P. 801–810.
  52. Gardner S.E., Frantz R.A. Wound bioburden and infection-related complications in diabetic foot ulcers // Biological Research for Nursing. NIH Public Access, 2008. Vol. 10, № 1. P. 44–53.
  53. Gardner S.E., Frantz R.A., Doebbeling B.N. The validity of the clinical signs and symptoms used to identify localized chronic wound infection // Wound Repair Regen. Wound Repair Regen, 2001. Vol. 9, № 3. P. 178–186.
  54. Joseph W.S., Lipsky B.A. Medical therapy of diabetic foot infections // J. Am. Podiatr. Med. Assoc. American Podiatric Medical Association, 2010. Vol. 100, № 5. P. 395–400.
  55. Cutting K.F., Harding K.G. Criteria for identifying wound infection // J. Wound Care. Mark Allen Group, 1994. Vol. 3, № 4. P. 198–201.
  56. Chamberlain D.J., Willis E.M., Bersten A.B. The severe sepsis bundles as processes of care: A meta-analysis // Australian Critical Care. Aust Crit Care, 2011. Vol. 24, № 4. P. 229–243.
  57. Levy M.M. et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference // Critical Care Medicine. Crit Care Med, 2003. Vol. 31, № 4. P. 1250–1256.
  58. Clements T.W. et al. Secondary Peritonitis and Intra-Abdominal Sepsis: An Increasingly Global Disease in Search of Better Systemic Therapies // Scandinavian Journal of Surgery. SAGE Publications Inc., 2021.
  59. Sepsis following Pregnancy, Bacterial (Green-top Guideline No. 64b) [Electronic resource]. URL: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg64b/ (accessed: 28.05.2021).
  60. Schrey-Petersen S. et al. Diseases and complications of the puerperium //Deutsches Ärzteblatt International. – 2021. – Т. 118. – №. 25. – С. 436.
  61. Malmir M. et al. Factors affecting postpartum infection: A systematic review //Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders). – 2022. – Т. 22. – №. 3. – С. 28-37.
  62. Gomaa K. et al. Incidence, risk factors and management of post cesarean section surgical site infection (SSI) in a tertiary hospital in Egypt: a five year retrospective study //BMC Pregnancy and Childbirth. – 2021. – Т. 21. – С. 1-9.
  63. Dalton E., Castillo E. Post partum infections: A review for the non-OBGYN //Obstetric medicine. – 2014. – Т. 7. – №. 3. – С. 98-102.
  64. Hannola K. et al. Obstetric early warning system to predict maternal morbidity of pre-eclampsia, postpartum hemorrhage and infection after birth in high-risk women: a prospective cohort study //Midwifery. – 2021. – Т. 99. – С. 103015.
  65. Rhodes A. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 // Intensive Care Med. Springer Verlag, 2017. Vol. 43, № 3. P. 304–377.
  66. Kruisselbrink R. et al. Modified Early Warning Score (MEWS) identifies critical illness among ward patients in a resource restricted setting in Kampala, Uganda: A prospective observational study // PLoS One. Public Library of Science, 2016. Vol. 11, № 3.
  67. World Health Organization. Reproductive Health and Research, World Health Organization Special Programme of Research D. WHO recommendations for prevention and treatment of maternal peripartum infections. 2015. 70 p.
  68. Kahlke V., Fischer A., Schröder J. Streptococcus pneumoniae peritonitis postpartum //Infection. – 2000. – Т. 28. – С. 114-115.
  69. Sadath S. A. et al. Vernix caseosa peritonitis after vaginal delivery //Clinical Medicine Insights: Case Reports. – 2013. – Т. 6. – С. CCRep. S12771.
  70. Boushra M., Rahman O. Postpartum Infection. – 2020.
  71. Serafim R. et al. A comparison of the quick-SOFA (qSOFA) and SIRS criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis // Chest. Elsevier, 2018. Vol. 153, № 3. P. 646–655.
  72. Bauer M. E. et al. Risk factors, etiologies, and screening tools for sepsis in pregnant women: a multicenter case-control study //Anesthesia and analgesia. – 2019. – Т. 129. – №. 6. – С. 1613.
  73. Evans L. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021 // Crit. Care Med. Ovid Technologies (Wolters Kluwer Health), 2021. Vol. 49, № 11. P. e1063–e1143.
  74. Bone R.C. et al. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis // Chest. Elsevier, 1992. Vol. 101, № 6. P. 1644–1655.
  75. Singh S. et al. A validation study of the CEMACH recommended modified early obstetric warning system (MEOWS) // Anaesthesia. Anaesthesia, 2012. Vol. 67, № 1. P. 12–18.
  76. Singh A. et al. Evaluation of maternal early obstetric warning system (MEOWS chart) as a predictor of obstetric morbidity: a prospective observational study // Eur. J. Obstet. Gynecol. Reprod. Biol. Elsevier Ireland Ltd, 2016. Vol. 207. P. 11–17.
  77. Bauer M.E. et al. Maternal physiologic parameters in relationship to systemic inflammatory response syndrome criteria: a systematic review and meta-analysis // Obstet. Gynecol. Obstet Gynecol, 2014. Vol. 124, № 3. P. 535–541.
  78. Albright C.M. et al. The Sepsis in Obstetrics Score: A model to identify risk of morbidity from sepsis in pregnancy // Am. J. Obstet. Gynecol. Mosby Inc., 2014. Vol. 211, № 1. P. 39.e1-39.e8.
  79. Agarwal R. et al. Comparison of sequential organ failure assessment (SOFA) and sepsis in obstetrics score (SOS) in women with pregnancy-associated sepsis with respect to critical care admission and mortality: A prospective observational study //The Journa.
  80. Dockree S. et al. White blood cells in pregnancy: reference intervals for before and after delivery //EBioMedicine. – 2021. – Т. 74. – С. 103715.
  81. Gowri V., Al-Zaabi M. A., Al Hosni M. K. M. Clinical usefulness of white blood cell count in detecting infection in postpartum women //European Journal of Obstetrics and Gynecology and Reproductive Biology. – 2016. – Т. 206. – С. e45.
  82. Яковлев А. Ю. и др. Влияние метаболической терапии на лёгочную дисфункцию у больных акушерским сепсисом //Антибиотики и химиотерапия. – 2011. – Т. 56. – №. 3-4. – С. 41-45.
  83. Cardoso T. et al. Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: Results from the Portuguese community-acquired sepsis study (SACiUCI study) // Crit. Care. Crit Care, 2010. Vol. 14, № 3.
  84. Weinstein M.P. et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. // Rev. Infect. Dis. Rev Infect Dis, 1983. Vol. 5, № 1. P. 35–53.
  85. Poole S., Kidd S.P., Saeed K. A review of novel technologies and techniques associated with identification of bloodstream infection etiologies and rapid antimicrobial genotypic and quantitative phenotypic determination // Expert Review of Molecular Diagnostics. Taylor and Francis Ltd, 2018. Vol. 18, № 6. P. 543–555.
  86. Clerc O. et al. Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-Negative Bacteremia: A prospective observational study // Clin. Infect. Dis. Clin Infect Dis, 2013. Vol. 56, № 8. P. 1101–1107.
  87. Forrest G.N. PNA FISH: Present and future impact on patient management // Expert Review of Molecular Diagnostics. Expert Rev Mol Diagn, 2007. Vol. 7, № 3. P. 231–236.
  88. Vlek A.L.M., Bonten M.J.M., Boel C.H.E. Direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry improves appropriateness of antibiotic treatment of bacteremia // PLoS One. Public Library of Science, 2012. Vol. 7, № 3. P. 32589.
  89. Гаврилов С.Н. et al. Современные молекулярно-генетические методы, используемые для этиологической диагностики сепсиса // Журнал микробиологии, эпидемиологии и иммунобиологии. 2016. Vol. 2. P. 91–99.
  90. Jansen T.C. et al. Early lactate-guided therapy in intensive care unit patients: A multicenter, open-label, randomized controlled trial // Am. J. Respir. Crit. Care Med. Am J Respir Crit Care Med, 2010. Vol. 182, № 6. P. 752–761.
  91. Jones A.E. et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial // JAMA - J. Am. Med. Assoc. American Medical Association, 2010. Vol. 303, № 8. P. 739–746.
  92. Yu B. et al. Comparison of the effect of fluid resuscitation as guided either by lactate clearance rate or by central venous oxygen saturation in patients with sepsis // Chinese Crit. Care Med. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2013. Vol. 25, № 10. P. 578–583.
  93. Gattinoni L. et al. Understanding lactatemia in human sepsis potential impact for early management // Am. J. Respir. Crit. Care Med. American Thoracic Society, 2019. Vol. 200, № 5. P. 582–589.
  94. Goyal P. et al. Serial serum lactic acid in pregnancy-associated sepsis for maternal outcome //The Journal of Obstetrics and Gynecology of India. – 2020. – Т. 70. – С. 342-348.
  95. Dockree S. et al. How should we interpret lactate in labour? A reference study //BJOG: An International Journal of Obstetrics & Gynaecology. – 2022. – Т. 129. – №. 13. – С. 2150-2156.
  96. Levy B. Lactate and shock state: The metabolic view // Current Opinion in Critical Care. Curr Opin Crit Care, 2006. Vol. 12, № 4. P. 315–321.
  97. Casserly B. et al. Lactate measurements in sepsis-induced tissue hypoperfusion: Results from the surviving sepsis campaign database // Crit. Care Med. Lippincott Williams and Wilkins, 2015. Vol. 43, № 3. P. 567–573.
  98. Faix J.D. Biomarkers of sepsis // Critical Reviews in Clinical Laboratory Sciences. Crit Rev Clin Lab Sci, 2013. Vol. 50, № 1. P. 23–36.
  99. Joyce C. M. et al. Reference values for C-reactive protein and procalcitonin at term pregnancy and in the early postnatal period //Annals of Clinical Biochemistry. – 2021. – Т. 58. – №. 5. – С. 452-460.
  100. Батракова Т. В. и др. Клиническая информативность определения уровня с-реактивного белка в прогнозировании развития послеродового эндометрита //Журнал акушерства и женских болезней. – 2020. – Т. 69. – №. 2. – С. 5-14.
  101. De Meeus J. B. et al. C-reactive protein levels at the onset of labour and at day 3 post-partum in normal pregnancy //Clinical and Experimental Obstetrics & Gynecology. – 1998. – Т. 25. – №. 1-2. – С. 9-11.
  102. Miyazaki K. et al. Postoperative C-reactive protein as a predictive marker for surgical site infection after cesarean section: Retrospective analysis of 748 patients at a Japanese academic institution //Plos one. – 2022. – Т. 17. – №. 9. – С. e0273683.
  103. Kääpä P., Koistinen E. Maternal and neonatal C‐reactive protein after interventions during delivery //Acta obstetricia et gynecologica Scandinavica. – 1993. – Т. 72. – №. 7. – С. 543-546.
  104. Mertens K., Muys J., Jacquemyn Y. Postpartum C-reactive protein: a limited value to detect infection or inflammation //Facts, Views & Vision in ObGyn. – 2019. – Т. 11. – №. 3. – С. 243.
  105. Yoon S. H. et al. Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis //BMC Infectious Diseases. – 2019. – Т. 19. – С. 1-11.
  106. Wu J. et al. Accuracy of presepsin in sepsis diagnosis: a systematic review and meta-analysis //PLoS One. – 2015. – Т. 10. – №. 7. – С. e0133057.
  107. Zhu Y. et al. The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: A meta-analysis // Ther. Clin. Risk Manag. Dove Medical Press Ltd., 2019. Vol. 15. P. 741–753.
  108. Khajavi M.R. et al. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit // Acta Med. Iran. 2015. P. 562–567.
  109. Layios N. et al. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients // Crit. Care Med. 2012. Vol. 40, № 8. P. 2304–2309.
  110. Jensen J.U. et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial. 2011.
  111. Plante L. A. Management of sepsis and septic shock for the obstetrician–gynecologist //Obstetrics and Gynecology Clinics. – 2016. – Т. 43. – №. 4. – С. 659-678.
  112. Liumbruno G. et al. Recommendations for the transfusion of plasma and platelets // Blood Transfusion. Blood Transfus, 2009. Vol. 7, № 2. P. 132–150.
  113. Iba T. et al. Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation //Journal of clinical medicine. – 2019. – Т. 8. – №. 5. – С. 728.
  114. Fan S. R. et al. New concept and management for sepsis in pregnancy and the puerperium //Maternal-Fetal Medicine. – 2020. – Т. 2. – №. 04. – С. 231-239.
  115. Аndy W Wong. Postpartum Infections Workup.
  116. Feng M. et al. Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database // Intensive Care Med. Springer Verlag, 2018. Vol. 44, № 6. P. 884–892.
  117. Alonso J. V. et al. Sepsis, fluid resuscitation and bedside echocardiography // QJM. Oxford University Press, 2018. Vol. 111, № 1. P. 51–52.
  118. McLean A.S. Echocardiography in shock management // Critical Care. BioMed Central Ltd., 2016. Vol. 20, № 1.
  119. Cecconi M. et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine // Intensive Care Med. Springer Verlag, 2014. Vol. 40, № 12. P. 1795–1815.
  120. Rhodes A. et al. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study) // Intensive Care Med. Springer Verlag, 2015. Vol. 41, № 9. P. 1620–1628.
  121. Власова В. В. и др. СЕПСИС В ПРАКТИКЕ АКУШЕРА (КЛИНИЧЕСКИЙ СЛУЧАЙ) //Мать и дитя в Кузбассе. – 2021. – №. 2 (85). – С. 113-119.
  122. Green L. J. et al. Postpartum-specific vital sign reference ranges //Obstetrics and gynecology. – 2021. – Т. 137. – №. 2. – С. 295.
  123. Gibbs R. et al. Improving diagnosis and treatment of maternal sepsis: a quality improvement toolkit. – 2020.
  124. Hall JE. Guyton and Hall Textbook of Medical Physiology. 13th Edition. 2015. 1–1168 p.
  125. Wang S.S., Shum D., Kennedy A. Imaging of Postpartum/Peripartum Complications // Radiologic Clinics of North America. W.B. Saunders, 2020. Vol. 58, № 2. P. 431–443.
  126. Steinkeler J., Coldwell B.J., Warner M.A. Ultrasound of the postpartum uterus // Ultrasound Quarterly. Ultrasound Q, 2012. Vol. 28, № 2. P. 97–103.
  127. Faure K et al. Postpartum endometritis: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines // Gynecol. Obstet. Fertil. Senol. Gynecol Obstet Fertil Senol, 2019. Vol. 47, № 5. P. 442–450.
  128. Lamy C. et al. Prise en charge des infections du post-partum // J. Gynecol. Obstet. Biol. la Reprod. J Gynecol Obstet Biol Reprod (Paris), 2012. Vol. 41, № 8. P. 886–903.
  129. Laifer-Narin S. L. et al. Multimodality imaging of the postpartum or posttermination uterus: evaluation using ultrasound, computed tomography, and magnetic resonance imaging //Current problems in diagnostic radiology. – 2014. – Т. 43. – №. 6. – С. 374-385.
  130. Rule C., Ashley L., Bergin C. Sonographic findings in acute puerperal endometritis //Australasian Journal of Ultrasound in Medicine. – 2018. – Т. 21. – №. 4. – С. 234-240.
  131. Gillies R., Ashley L., Bergin C. Sonographic findings in acute puerperal endometritis: The hypoechoic rim sign and endomyometrial junction indistinctness //Australasian Journal of Ultrasound in Medicine. – 2017. – Т. 20. – №. 3. – С. 123-128.
  132. Sartelli M. et al. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections // World J. Emerg. Surg. 2017. Vol. 12. P. 29.
  133. Chen S. C. et al. Accuracy of ultrasonography in the diagnosis of peritonitis compared with the clinical impression of the surgeon //Archives of Surgery. – 2000. – Т. 135. – №. 2. – С. 170-174.
  134. Gado A., Badawi H., Karim A. An unusual case of peritonitis following a caesarean delivery //Alexandria journal of medicine. – 2018. – Т. 54. – №. 4. – С. 369-371.
  135. Andeweg C.S. et al. Toward an evidence-based step-up approach in diagnosing diverticulitis // Scandinavian Journal of Gastroenterology. Informa Healthcare, 2014. Vol. 49, № 7. P. 775–784.
  136. Shah B.R. et al. Value of short-interval computed tomography when sonography fails to visualize the appendix and shows otherwise normal findings // J. Ultrasound Med. American Institute of Ultrasound in Medicine, 2014. Vol. 33, № 9. P. 1589–1595.
  137. Koo H.S. et al. Does computed tomography have any additional value after sonography in patients with suspected acute appendicitis? // J. Ultrasound Med. John Wiley and Sons Ltd, 2013. Vol. 32, № 8. P. 1397–1403.
  138. Ganapathy A. et al. Routine chest x-rays in intensive care units: A systematic review and meta-analysis // Crit. Care. Crit Care, 2012. Vol. 16, № 2.
  139. Briones-Claudett K. H. et al. Invasive Subacute Pulmonary Aspergillosis After Puerperal Sepsis: Case Report //Journal of Investigative Medicine High Impact Case Reports. – 2020. – Т. 8. – С. 2324709620977707.
  140. Sakamoto K. et al. A cured case of adult respiratory distress syndrome caused by septicemia of Staphylococcus aureus //The Japanese journal of thoracic diseases. – 1989. – Т. 27. – №. 12. – С. 1551-1555.
  141. Mazzeffi M. A., Chen K. T. Severe postpartum sepsis with prolonged myocardial dysfunction: a case report //Journal of Medical Case Reports. – 2010. – Т. 4. – №. 1. – С. 1-3.
  142. Papazian L. et al. Diagnostic workup for ARDS patients // Intensive Care Medicine. Springer Verlag, 2016. Vol. 42, № 5. P. 674–685.
  143. Malbrain M.L.N.G. et al. Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: A multiple-center epidemiological study // Crit. Care Med. Crit Care Med, 2005. Vol. 33, № 2. P. 315–322.
  144. Vignon P. Continuous cardiac output assessment or serial echocardiography during septic shock resuscitation? // Ann. Transl. Med. 2020. Vol. 8, № 12. P. 797–797.
  145. Valeanu L. et al. Hemodynamic Monitoring in Sepsis—A Conceptual Framework of Macro- and Microcirculatory Alterations // Diagnostics. 2021. Vol. 11, № 9. P. 1559.
  146. Ritter S., Rudiger A., Maggiorini M. Transpulmonary thermodilution-derived cardiac function index identifies cardiac dysfunction in acute heart failure and septic patients: an observational study //Critical Care. – 2009. – Т. 13. – С. 1-10.
  147. Liu X. et al. Application strategy of PiCCO in septic shock patients //Experimental and Therapeutic Medicine. – 2016. – Т. 11. – №. 4. – С. 1335-1339.
  148. Bijl R. C. et al. Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics //Ultrasound in Obstetrics & Gynecology. – 2019. – Т. 54. – №. 1. – С. 35-50.
  149. Zuarez-Easton S. et al. Postcesarean wound infection: prevalence, impact, prevention, and management challenges // Int. J. Womens. Health. Dove Press, 2017. Vol. 9. P. 81.
  150. MacMillan A. et al. Multidisciplinary approach to improve sepsis outcomes //The Journal for Healthcare Quality (JHQ). – 2019. – Т. 41. – №. 4. – С. 220-227.
  151. Halstead D. C. Can Multidisciplinary Sepsis Teams Help Solve a Global Concern? A Review of the Literature //Clinical Microbiology Newsletter. – 2022. – Т. 44. – №. 15. – С. 131-137.
  152. Хирургические инфекции кожи и мягких тканей. Российские национальные рекомендации. 2015. 1–111 p.
  153. National Collaborating Centre for Women’s and Children’s Health, National Institute for Health and Clinical Excellence. Clinical guideline CG44: heavy menstrual bleeding. London: Royal College of Obstetricians and Gynaecologists.
  154. Stadelmann W.K., Digenis A.G., Tobin G.R. Impediments to wound healing // Am. J. Surg. Elsevier Inc., 1998. Vol. 176, № 2 A. P. 39S-47S.
  155. Wechter M.E., Pearlman M.D., Hartmann K.E. Reclosure of the disrupted laparotomy wound: A systematic review // Obstetrics and Gynecology. Lippincott Williams and Wilkins, 2005. Vol. 106, № 2. P. 376–383.
  156. Орлова Н. В. АНТИБИОТИКОРЕЗИСТЕНТНОСТЬ И СОВРЕМЕННАЯ СТРАТЕГИЯ АНТИБАКТЕРИАЛЬНОЙ ТЕРАПИИ //Медицинский совет. – 2022. – Т. 16. – №. 8. – С. 89-97.
  157. Гучев И. А., Французов В. Н. Рациональная антибактериальная терапия тяжелых хирургических инфекций //Русский медицинский журнал. – 2006. – Т. 14. – №. 15. – С. 1135-1140.
  158. Козлов Р. С., Голуб А. В. Ципрофлоксацин в современной клинической практике //Клиническая микробиология и антимикробная химиотерапия. – 2010. – Т. 12. – №. 2. – С. 154-162.
  159. Meaney-Delman, D., Bartlett, L. A., Gravett, M. G., & Jamieson, D. J. (2015). Oral and Intramuscular Treatment Options for Early Postpartum Endometritis in Low-Resource Settings. Obstetrics & Gynecology, 125(4), 789–800. doi:10.1097/aog.0000000000000732.
  160. Morrissey I. et al. A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011 // Pharmaceuticals. MDPI AG, 2013. Vol. 6, № 11. P. 1335–1346.
  161. Kurup A. et al. Antibiotic management of complicated intra-abdominal infections in adults: The Asian perspective // Annals of Medicine and Surgery. Elsevier, 2014. Vol. 3, № 3. P. 85–91.
  162. Damiani E. et al. Effect of performance improvement programs on compliance with sepsis bundles and mortality: A systematic review and meta-analysis of observational studies // PLoS ONE. Public Library of Science, 2015. Vol. 10, № 5.
  163. Seymour C.W. et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis // N. Engl. J. Med. Massachusetts Medical Society, 2017. Vol. 376, № 23. P. 2235–2244.
  164. Leisman D.E. et al. Survival Benefit and Cost Savings from Compliance with a Simplified 3-Hour Sepsis Bundle in a Series of Prospective, Multisite, Observational Cohorts // Crit. Care Med. Lippincott Williams and Wilkins, 2017. Vol. 45, № 3. P. 395–406.
  165. Ferrer R. et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program // Crit. Care Med. Lippincott Williams and Wilkins, 2014. Vol. 42, № 8. P. 1749–1755.
  166. Gaieski D.F. et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department // Crit. Care Med. Lippincott Williams and Wilkins, 2010. Vol. 38, № 4. P. 1045–1053.
  167. Barochia A. V. et al. Bundled care for septic shock: An analysis of clinical trials // Critical Care Medicine. Lippincott Williams and Wilkins, 2010. Vol. 38, № 2. P. 668–678.
  168. Kumar A. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock // Crit. Care Med. Crit Care Med, 2006. Vol. 34, № 6. P. 1589–1596.
  169. Белобородов В.Б., Голощапов О.В., Гусаров В.Г.  и др. Методические рекомендации “Диагностика и антимикробная терапия инфекций, вызванных полирезистентными штаммами микроорганизмов” (обновление 2022 г.) // Вестник анестезиологии и реаниматологии. № Том 19, Т2. P. 84–114.
  170. Яковлева С.В. et al. Программа СКАТ (Стратегия Контроля Антимикробной Терапии) при оказании стационарной медицинской помощи: Российские клинические рекомендации. 2018. 1–156 p.
  171. Garnacho-Montero J. et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock // Intensive Care Med. Intensive Care Med, 2014. Vol. 40, № 1. P. 32–40.
  172. Morel J. et al. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit // Crit. Care. Crit Care, 2010. Vol. 14, № 6.
  173. Leone M. et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial // Intensive Care Med. Springer Verlag, 2014. Vol. 40, № 10. P. 1399–1408.
  174. Guo Y. et al. De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: A meta-analysis // Hear. Lung J. Acute Crit. Care. Mosby Inc., 2016. Vol. 45, № 5. P. 454–459.
  175. Plante LA. Diagnosis and Management of Sepsis and Septic Shock in Pregnancy and the Puerperium | Article | GLOWM // The Continuous Textbook of Women’s Medicine Series – Obstetrics Module . 2021. Vol. 9.
  176. Misango D. et al. Haemodynamic assessment and support in sepsis and septic shock in resource-limited settings // Trans. R. Soc. Trop. Med. Hyg. Trans R Soc Trop Med Hyg, 2017. Vol. 111, № 11. P. 483–489.
  177. Cherpanath T.G.V. et al. Predicting Fluid Responsiveness by Passive Leg Raising: A Systematic Review and Meta-Analysis of 23 Clinical Trials // Crit. Care Med. Crit Care Med, 2016. Vol. 44, № 5. P. 981–991.
  178. Aya H.D. et al. Hemodynamic Effect of Different Doses of Fluids for a Fluid Challenge: A Quasi-Randomized Controlled Study // Crit. Care Med. Crit Care Med, 2017. Vol. 45, № 2. P. e161–e168.
  179. Ehrman R.R. et al. Critical Care Explorations Critical Care Explorations Resuscitation Guided by Volume Responsiveness Does Not Reduce Mortality in Sepsis: A Meta-Analysis. 2019.
  180. Rochwerg B. et al. Fluid resuscitation in sepsis: A systematic review and network meta-analysis // Annals of Internal Medicine. American College of Physicians, 2014. Vol. 161, № 5. P. 347–355.
  181. Semler M.W. et al. Balanced Crystalloids versus Saline in Critically Ill Adults // N. Engl. J. Med. N Engl J Med, 2018. Vol. 378, № 9. P. 829–839.
  182. Finfer S. et al. The SAFE study: saline vs. albumin for fluid resuscitation in the critically ill // Vox Sang. Wiley, 2004. Vol. 87, № s2. P. 123–131.
  183. Delaney A.P. et al. The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis // Critical Care Medicine. Lippincott Williams and Wilkins, 2011. Vol. 39, № 2. P. 386–391.
  184. Xu J.Y. et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: A meta-analysis of randomized clinical trials // Crit. Care. BioMed Central Ltd., 2014. Vol. 18, № 6.
  185. Haase N. et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-analysis and trial sequential analysis // BMJ. British Medical Journal Publishing Group, 2013. Vol. 346, № 7900.
  186. Avni T. et al. Vasopressors for the treatment of septic shock: Systematic review and meta-analysis // PLoS One. Public Library of Science, 2015. Vol. 10, № 8. P. e0129305.
  187. Ruslan M. A. et al. Norepinephrine in septic shock: a systematic review and meta-analysis //Western Journal of Emergency Medicine. – 2021. – Т. 22. – №. 2. – С. 196.
  188. Regnier B. et al. Haemodynamic effects of dopamine in septic shock // Intensive Care Med. Springer-Verlag, 1977. Vol. 3, № 2. P. 47–53.
  189. Gamper G. et al. Vasopressors for hypotensive shock // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2016. Vol. 2016, № 2.
  190. Belletti A. et al. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials // J. Crit. Care. J Crit Care, 2017. Vol. 37. P. 91–98.
  191. Annane D. et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial // Lancet. Elsevier B.V., 2007. Vol. 370, № 9588. P. 676–684.
  192. Hollenberg S.M. et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 Update // Critical Care Medicine. Crit Care Med, 2004. Vol. 32, № 9. P. 1928–1948.
  193. Bhattacharjee S. et al. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials // J. Clin. Anesth. Elsevier, 2017. Vol. 39. P. 67–72.
  194. Gordon A.C. et al. Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis // N. Engl. J. Med. N Engl J Med, 2016. Vol. 375, № 17. P. 1638–1648.
  195. Ricard J.D. et al. Central or peripheral catheters for initial venous access of ICU patients: A randomized controlled trial // Crit. Care Med. 2013. Vol. 41, № 9. P. 2108–2115.
  196. Delaney A. et al. Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: A retrospective cohort study // Emerg. Med. Australas. John Wiley & Sons, Ltd, 2020. Vol. 32, № 2. P. 210–219.
  197. Huh J.W. et al. Low-dose hydrocortisone treatment for patients with septic shock: A pilot study comparing 3 days with 7 days // Respirology. Respirology, 2011. Vol. 16, № 7. P. 1088–1095.
  198. Venkatesh B. et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock // N. Engl. J. Med. Massachusetts Medical Society, 2018. Vol. 378, № 9. P. 797–808.
  199. Rygård S.L. et al. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis // Intensive Care Med. 2018 447. Springer, 2018. Vol. 44, № 7. P. 1003–1016.
  200. Annane D. et al. Corticosteroids for treating sepsis //Cochrane database of systematic reviews. – 2015. – №. 12.
  201. Liang H. et al. Corticosteroids for treating sepsis in adult patients: A systematic review and meta-analysis //Frontiers in Immunology. – 2021. – Т. 12. – С. 709155.
  202. Annane D. et al. Corticosteroids for treating sepsis in children and adults // Emergencias. Saned, 2021. Vol. 33, № 2. P. 137–138.
  203. Weber-Carstens S. et al. Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients // Intensive Care Med. Intensive Care Med, 2007. Vol. 33, № 4. P. 730–733.
  204. Hirano Y. et al. Liberal versus restrictive red blood cell transfusion strategy in sepsis or septic shock: A systematic review and meta-analysis of randomized trials // Crit. Care. BioMed Central Ltd., 2019. Vol. 23, № 1.
  205. Holst L.B. et al. Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock // N. Engl. J. Med. New England Journal of Medicine (NEJM/MMS), 2014. Vol. 371, № 15. P. 1381–1391.
  206. Kaufman R.M. et al. Platelet transfusion: A clinical practice guideline from the AABB // Annals of Internal Medicine. American College of Physicians, 2015. Vol. 162, № 3. P. 205–213.
  207. Stanworth S.J. et al. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME) // Transfusion. Blackwell Publishing Inc., 2014. Vol. 54, № 10. P. 2385–2393.
  208. Allingstrup M. et al. Antithrombin III for critically ill patients // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2016. Vol. 2016, № 2.
  209. Warren B.L. et al. High-dose antithrombin III in severe sepsis: A randomized controlled trial // J. Am. Med. Assoc. American Medical Association, 2001. Vol. 286, № 15. P. 1869–1878.
  210. Morton A. Physiological Changes and Cardiovascular Investigations in Pregnancy // Heart. Lung Circ. Heart Lung Circ, 2021. Vol. 30, № 1. P. e6–e15.
  211. Neto A.S. et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: A meta-analysis // JAMA - J. Am. Med. Assoc. JAMA, 2012. Vol. 308, № 16. P. 1651–1659.
  212. Kim W.Y., Hong S.B. Sepsis and acute respiratory distress syndrome: Recent update // Tuberculosis and Respiratory Diseases. Korean National Tuberculosis Association, 2016. Vol. 79, № 2. P. 53–57.
  213. Takeuchi M., Tachibana K. Mechanical Ventilation for ARDS Patients – For a Better Understanding of the 2012 Surviving Sepsis Campaign Guidelines // Cardiovasc. Hematol. Disord. Targets. Bentham Science Publishers Ltd., 2015. Vol. 15, № 1. P. 41–45.
  214. Goligher E.C., Douflé G., Fan E. Update in mechanical ventilation, sedation, and outcomes 2014 // Am. J. Respir. Crit. Care Med. American Thoracic Society, 2015. Vol. 191, № 12. P. 1367–1373.
  215. Lellouche F. et al. High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery // Anesthesiology. Anesthesiology, 2012. Vol. 116, № 5. P. 1072–1082.
  216. Aggarwal N.R. et al. Oxygen Exposure Resulting in Arterial Oxygen Tensions Above the Protocol Goal Was Associated With Worse Clinical Outcomes in Acute Respiratory Distress Syndrome // Crit. Care Med. NLM (Medline), 2018. Vol. 46, № 4. P. 517–524.
  217. Brower RG et al. Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome // N. Engl. J. Med. New England Journal of Medicine (NEJM/MMS), 2000. Vol. 342, № 18. P. 1301–1308.
  218. Marini J.J., Gattinoni L. Ventilatory management of acute respiratory distress syndrome: A consensus of two // Critical Care Medicine. Lippincott Williams and Wilkins, 2004. Vol. 32, № 1. P. 250–255.
  219. Briel M. et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: Systematic review and meta-analysis // JAMA - Journal of the American Medical Association. American Medical Association, 2010. Vol. 303, № 9. P. 865–873.
  220. Goligher E.C. et al. Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome: A secondary analysis of the LOVS and express trials // Am. J. Respir. Crit. Care Med. American Thoracic Society, 2014. Vol. 190, № 1. P. 70–76.
  221. Guo L. et al. Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: A systematic review and meta-analysis // BMC Anesthesiol. BioMed Central Ltd., 2018. Vol. 18, № 1.
  222. Oba Y., Thameem D.M., Zaza T. High levels of PEEP may improve survival in acute respiratory distress syndrome: A meta-analysis // Respir. Med. Respir Med, 2009. Vol. 103, № 8. P. 1174–1181.
  223. Clancy C.J., Nguyen H. Diagnosing Invasive Candidiasis. 2018.
  224. Köhler P., Cornely O.A., Vehreschild · J J. Der Internist Schwerpunkt: Opportunistische Infektionen // Internist (Berl).
  225. Von Lilienfeld-Toal M. et al. Invasive Fungal Infection // Dtsch. Arztebl. Int. Dtsch Arztebl Int, 2019. Vol. 116, № 16. P. 271–278.
  226. Andes D.R. et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials // Clin. Infect. Dis. Clin Infect Dis, 2012. Vol. 54, № 8. P. 1110–1122.
  227. Zhang Z. et al. Original research: Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis // BMJ Open. BMJ Publishing Group, 2020. Vol. 10, № 7. P. 36452.
  228. Phua A.I.H. et al. Candida catheter-related bloodstream infection in patients on home parenteral nutrition - Rates, risk factors, outcomes, and management // Clin. Nutr. ESPEN. Clin Nutr ESPEN, 2019. Vol. 31. P. 1–9.
  229. Serefhanoglu K. et al. Risk factors for candidemia with non-albicans Candida spp. in intensive care unit patients with end-stage renal disease on chronic hemodialysis // J. Formos. Med. Assoc. J Formos Med Assoc, 2012. Vol. 111, № 6. P. 325–332.
  230. Siegelaar SE et al. Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study // Crit. Care. Crit Care, 2010. Vol. 14, № 6.
  231. Badawi O et al. Association between intensive care unit-acquired dysglycemia and in-hospital mortality // Crit. Care Med. Crit Care Med, 2012. Vol. 40, № 12. P. 3180–3188.
  232. Finfer S et al. Hypoglycemia and risk of death in critically ill patients // N. Engl. J. Med. N Engl J Med, 2012. Vol. 367, № 12. P. 1108–1118.
  233. Kalfon P et al. Severe and multiple hypoglycemic episodes are associated with increased risk of death in ICU patients // Crit. Care. Crit Care, 2015. Vol. 19, № 1.
  234. Todi S, Bhattacharya M. Glycemic variability and outcome in critically ill // Indian J. Crit. Care Med. Indian J Crit Care Med, 2014. Vol. 18, № 5. P. 285–290.
  235. Yatabe T. et al. The optimal target for acute glycemic control in critically ill patients: a network meta-analysis // Intensive Care Med. Springer Verlag, 2017. Vol. 43, № 1. P. 16–28.
  236. Kakkos S. et al. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism // Cochrane Database Syst. Rev. John Wiley and Sons, Inc. and the Cochrane Library, 2022. Vol. 2022, № 1.
  237. Junqueira D.R. et al. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients // Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2012. № 9.
  238. Wang C. et al. Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis //Critical care. – 2014. – Т. 18. – С. 1-9.
  239. Li X. et al. Therapeutic effect of low-molecular-weight heparin on adult sepsis: a meta-analysis //Ann Palliat Med. Mar. – 2021. – Т. 10. – С. 3115-3127.
  240. Fu S. et al. Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis //BMC anesthesiology. – 2022. – Т. 22. – №. 1. – С. 1-12.
  241. Kahn S.R. et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines // Chest. American College of Chest Physicians, 2012. Vol. 141, № 2 SUPPL. P. e195S-e226S.
  242. Azuhata T. et al. Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock // Crit. Care. BioMed Central Ltd., 2014. Vol. 18, № 3.
  243. Chao W.N. et al. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis // Am. J. Surg. Am J Surg, 2013. Vol. 206, № 1. P. 32–39.
  244. Buck D.L., Vester-Andersen M., Møller M.H. Surgical delay is a critical determinant of survival in perforated peptic ulcer // Br. J. Surg. Br J Surg, 2013. Vol. 100, № 8. P. 1045–1049.
  245. Bloos F. et al. Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: A prospective observational multi-center study // Crit. Care. BioMed Central Ltd., 2014. Vol. 18, № 2.
  246. Elton R.J., Chaudhari S. Sepsis in obstetrics // BJA Educ. Elsevier Ltd, 2015. Vol. 15, № 5. P. 259–264.
  247. Van Den Akker T. et al. Prevalence, Indications, Risk Indicators, and Outcomes of Emergency Peripartum Hysterectomy Worldwide: A Systematic Review and Meta-analysis // Obstet. Gynecol. Lippincott Williams and Wilkins, 2016. Vol. 128, № 6. P. 1281–1294.
  248. Solomons B. Two cases of puerperal sepsis treated by hysterectomy. – 1928.
  249. 249.  Sebitloane M. H., Moodley J. Emergency peripartum hysterectomy //East African medical journal. – 2001. – Т. 78. – №. 2. – С. 70-74.
  250. Guérin C. et al. Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: Results from a multicenter prospective epidemiological survey // Intensive Care Med. Intensive Care Med, 2002. Vol. 28, № 10. P. 1411–1418.
  251. Zha J. et al. The efficacy of renal replacement therapy strategies for septic-acute kidney injury: A PRISMA-compliant network meta-analysis //Medicine. – 2019. – Т. 98. – №. 16.
  252. Gaudry S. et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit // N. Engl. J. Med. New England Journal of Medicine (NEJM/MMS), 2016. Vol. 375, № 2. P. 122–133.
  253. Zarbock A. et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The elain randomized clinical trial // JAMA - J. Am. Med. Assoc. American Medical Association, 2016. Vol. 315, № 20. P. 2190–2199.
  254. Barbar S. D. et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis //New England Journal of Medicine. – 2018. – Т. 379. – №. 15. – С. 1431-1442.
  255. Alejandria M.M. et al. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2013. Vol. 2013, № 9.
  256. Borthwick E.M.J. et al. High-volume haemofiltration for sepsis in adults // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2017. Vol. 2017, № 1.
  257. Rimmer E. et al. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: A systematic review and meta-analysis // Crit. Care. BioMed Central Ltd., 2014. Vol. 18, № 1. P. 1–8.
  258. David S. et al. Adjuvant therapeutic plasma exchange in septic shock // Intensive Care Med. Intensive Care Med, 2021. Vol. 47, № 3. P. 352–354.
  259. Гельфанд Б.Р. и др. Сепсис: классификация, клинико-диагностическая концепция и лечение / Под ред. акад. РАН Б.Р. Гельфанда. — 4-е изд., доп. и перераб. Москва: ООО «Медицинское информационное агентство», 2017. 229–255 p.
  260. Padmanabhan A. et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue // J. Clin. Apher. John Wiley & Sons, Ltd, 2019. Vol. 34, № 3. P. 171–354.
  261. Knaup H. et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers // Crit. Care. Crit Care, 2018. Vol. 22, № 1.
  262. Keith P.D. et al. The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: A single-center experience // Crit. Care. BioMed Central Ltd, 2020. Vol. 24, № 1.
  263. Krag M et al. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis // Intensive Care Med. Intensive Care Med, 2014. Vol. 40, № 1. P. 11–22.
  264. Alhazzani A et al. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis // Crit. Care Med. Crit Care Med, 2013. Vol. 41, № 3. P. 693–705.
  265. Barkun AN et al. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis // Am. J. Gastroenterol. Am J Gastroenterol, 2012. Vol. 107, № 4. P. 507–520.
  266. Alshamsi F et al. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials // Crit. Care. Crit Care, 2016. Vol. 20, № 1.
  267. Лебедева Е. Ю. и др. Комплексная методика восстановления женщины в послеродовом периоде //Вестник Российского университета дружбы народов. Серия: Медицина. – 2014. – №. 4. – С. 34-42.
  268. Prescott H. C., Angus D. C. Enhancing recovery from sepsis: a review //Jama. – 2018. – Т. 319. – №. 1. – С. 62-75.
  269. Mostel Z. et al. Post-sepsis syndrome–an evolving entity that afflicts survivors of sepsis //Molecular Medicine. – 2020. – Т. 26. – С. 1-14.
  270. Dol J. et al. Timing of maternal mortality and severe morbidity during the postpartum period: a systematic review //JBI Evidence Synthesis. – 2022. – Т. 20. – №. 9. – С. 2119-2194.
  271. Buppasiri P. et al. Antibiotic prophylaxis for third- and fourth-degree perineal tear during vaginal birth // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2014. Vol. 2014, № 10.
  272. Marić T., Tomić V., Darko K. Puerperal complications in nulliparous women delivered by section caesarean: pair study //Medicinski Arhiv. – 2006. – Т. 60. – №. 4. – С. 246-250.
  273. Bodner K. et al. Influence of the mode of delivery on maternal and neonatal outcomes: a comparison between elective cesarean section and planned vaginal delivery in a low-risk obstetric population //Archives of gynecology and obstetrics. – 2011. – Т. 283.
  274. Косова А. А., Чалапа В. И. Инфекции, связанные с оказанием медицинской помощи, в стационарах России: опыт мета-анализа заболеваемости //Здоровье населения и среда обитания. – 2018. – №. 12 (309). – С. 57-63.
  275. World Health Organization et al. Increased incidence of scarlet fever and invasive Group A Streptococcus infection-multi-country //2022-12-15)[2022-12-18]. https://www. who. int/emergencies/disease-outbreak-news/item/2022-DON429. – 2022.
  276. Chuang I. et al. Population-based surveillance for postpartum invasive group a streptococcus infections, 1995–2000 //Clinical Infectious Diseases. – 2002. – Т. 35. – №. 6. – С. 665-670.
  277. Daneman N. et al. Hospital-acquired invasive group A streptococcal infections in Ontario, Canada, 1992–2000 //Clinical infectious diseases. – 2005. – Т. 41. – №. 3. – С. 334-342.
  278. Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers .

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*